Eye Journal

Meet the Editors in Chief of EYE and EYE OPEN at RCOphth Congress An opportunity to ask what the editors look for in an article and find out about publishing, review, and editorial work. - Find us at the EXHIBITION THEATRE - MONDAY 18 MAY, 13:15-14:00 #Ophthalmology #EyeConUK

In collaboration with Springer Nature’s leading ophthalmology journal, Eye, our upcoming CME-accredited webinar will cover the latest developments in the diagnosis, grading, and management of #DryEyeDisease. Register now 👉️ buff.ly/WC3aiko #EyeMed @Eye_Journal

#DryEyeDisease is widespread and can affect comfort, vision, and daily life, yet its causes and symptoms vary. In this webinar, discover how new research and clinical tools are changing how the condition is assessed and managed. 👉buff.ly/ghkOzp9 #EyeMed @Eye_Journal

Inviting submissions for a Special Collection on Real-Word Data in #Ophthalmology, with interest in studies using TriNetX and other large databases - Proposals by: 30 May 2026 - Submissions by: 30 Aug 2026 Guest Editors: Tiarnan Keenan and Itay Nitzan nature.com/eye/

Soft tissue filler use is rising, and so are serious complications. New UK consensus guidelines in Eye set out how to manage tissue filler induced vision loss. Cases have increased worldwide. Rapid recognition and referral are critical. nature.com/articles/s4143… #Ophthalmology

#DryEye disease can seriously impact quality of life, yet it’s often hard to diagnose and manage. Join our expert led webinar to learn how new science, better diagnostics, and emerging treatments are improving long term care. 👉 buff.ly/ghkOzp9 #EyeMed @Eye_Journal

We’re delighted to announce a new special section in @Eye_Journal on Thyroid Eye Disease and Orbital Inflammation. This is a timely moment: clinical trials, translational science and targeted therapies are reshaping how we think about inflammatory orbital disease, patient selection, outcomes and service design. #TED #OrbitalInflammation #Ophthalmology #ClinicalTrials nature.com/eye eye@rcophth.ac.uk

Call for submissions: Eye Special Section on Thyroid Eye Disease and Orbital Inflammation Share research on clinical care, therapies, imaging, and outcomes Expressions of Interest: 30 June 2026 Deadline: 30 Dec 2026 Editors: Vickie Lee, @DrNimaGhadiri nature.com/eye/

IIH is rising, but UK care is inconsistent. Audits show gaps in diagnosis, visual assessment, and weight management. Key standards are often missed. Structured pathways improve care. A national standard like RISE-IIH could close the gap. #OpenAccess nature.com/articles/s4143…

DED is highly prevalent yet challenging to diagnose and treat. Join us and discover the latest developments in pathogenesis, diagnostics, and therapies, and gain practical guidance on DED management. Register now 👉 buff.ly/ghkOzp9 #EyeMed #DryEye @Eye_Journal

Inequality in nAMD outcomes starts before treatment New NOD AMD Audit data shows patients from deprived communities present later and have poorer outcomes, despite similar NHS care Early detection and access must improve Read more: nature.com/articles/s4143… #AMD #Ophthalmology

The first UK consensus paper on managing Dry Eye Disease relevant to the NHS, detailing the patient pathway from primary to tertiary care involving optometrists, nurse practitioners, general and specialist ophthalmologists. Read #OpenAccess here: nature.com/articles/s4143… #DryEye

[EYE OPEN] Study on persistent epithelial defects is the first to monitor the morphology of both cryopreserved amniotic membrane and Omnigen membrane, and the first to use Omnigen as an inlay and onlay procedure and compare outcomes with CAMT. nature.com/articles/s4444… #OpenAccess

Naomi Tan and I are delighted to invite you to the Paediatric Ophthalmology Symposium at the @RCOphth Annual Congress 2026 in Manchester. Early bird registration is open until 24th March 2026: rcophth.ac.uk/events-courses… Please share! See you there 👀

[EYE OPEN] New review highlights key updates to the English Diabetic Eye Screening Programme: • 2-year screening for some low-risk patients • R2 retinopathy split into low/high risk • OCT used to refine maculopathy referrals Read #OpenAccess here: nature.com/articles/s4444…

Eye Reader’s Choice 2024–2025 Discover the most read and cited articles from Eye over the past two years. This collection brings together influential research, insightful reviews and expert commentary from across #ophthalmology. nature.com/collections/hi…

Pleased to share our paper published in @Eye_Journal: Feasibility and reproducibility of handheld and table-mounted optical coherence tomography in children with craniosynostosis nature.com/articles/s4143…

[Eye Open] Study finds macular disease patients are broadly accepting of AI in treatment decisions. Patients prioritise accuracy, speed, and the presence of a checking mechanism when considering the adoption of AI in treatment nature.com/articles/s4444… #Ophthalmology #OpenAccess

Members of The Royal College of Ophthalmologists can now publish colour figures in Eye at no additional cost. Benefit applies to the corresponding author and standard publication. Contact the Eye Editorial Office for full details. nature.com/eye/

New study shows a 23G trocar sleeve adapter can dramatically speed up silicone oil injection during vitreoretinal surgery. Injection time fell from 259s to 90s for Densiron 68, and from 774s to 153s for Silicone 5000 nature.com/articles/s4143… #Ophthalmology #OpenAccess